Skip to main content
Top
Published in: Current Atherosclerosis Reports 6/2015

01-06-2015 | Vascular Biology (T Hla, Section Editor)

Potential Contributions of Intimal and Plaque Hypoxia to Atherosclerosis

Author: Guo-Hua Fong

Published in: Current Atherosclerosis Reports | Issue 6/2015

Login to get access

Abstract

Injury of arterial endothelium by abnormal shear stress and other insults induces migration and proliferation of vascular smooth muscle cells (VSMCs), which in turn leads to intimal thickening, hypoxia, and vasa vasorum angiogenesis. The resultant new blood vessels extend from the tunica media into the outer intima, allowing blood-borne oxidized low-density lipoprotein (oxLDL) particles to accumulate in outer intimal tissues by extravasation through local capillaries. In response to oxLDL accumulation, monocytes infiltrate into arterial wall tissues, where they differentiate into macrophages and subsequently evolve into foam cells by uptaking large quantities of oxLDL particles, the latter process being stimulated by hypoxia. Increased oxygen demand due to expanding macrophage and foam cell populations contributes to persistent hypoxia in plaque lesions, whereas hypoxia further promotes plaque growth by stimulating angiogenesis, monocyte infiltration, and oxLDL uptake into macrophages. Molecularly, the accumulation of hypoxia-inducible factor (HIF)-1α and the expression of its target genes mediate many of the hypoxia-induced processes during plaque initiation and growth. It is hoped that further understanding of the underlying mechanisms may lead to novel therapies for effective intervention of atherosclerosis.
Literature
4.
go back to reference Ismail A, Khosravi H, Olson H. The role of infection in atherosclerosis and coronary artery disease: a new therapeutic target. Heart Dis. 1999;1(4):233–40.PubMed Ismail A, Khosravi H, Olson H. The role of infection in atherosclerosis and coronary artery disease: a new therapeutic target. Heart Dis. 1999;1(4):233–40.PubMed
5.
10.••
go back to reference Subbotin VM. Neovascularization of coronary tunica intima (DIT) is the cause of coronary atherosclerosis. Lipoproteins invade coronary intima via neovascularization from adventitial vasa vasorum, but not from the arterial lumen: a hypothesis. Theor Biol Med Model. 2012;9:11. doi:10.1186/1742-4682-9-11. This article prevents a novel hypothesis, accompanied with data and illustration, which argue that angiogenesis in the outer intimal tissues, is a critical requirement which allows the entry of oxLDL particles into arterial vascular wall tissues. This hypothesis contrasts the traditional concept that oxLDL enter the vascular wall through injured arterial vascular endothelium. The concept that angiogenesis controls the initiation of atherosclerotic development may lead to the identification of new therapeutic targets for the prevention and treatment of atherosclerosis.CrossRefPubMedCentralPubMed Subbotin VM. Neovascularization of coronary tunica intima (DIT) is the cause of coronary atherosclerosis. Lipoproteins invade coronary intima via neovascularization from adventitial vasa vasorum, but not from the arterial lumen: a hypothesis. Theor Biol Med Model. 2012;9:11. doi:10.​1186/​1742-4682-9-11. This article prevents a novel hypothesis, accompanied with data and illustration, which argue that angiogenesis in the outer intimal tissues, is a critical requirement which allows the entry of oxLDL particles into arterial vascular wall tissues. This hypothesis contrasts the traditional concept that oxLDL enter the vascular wall through injured arterial vascular endothelium. The concept that angiogenesis controls the initiation of atherosclerotic development may lead to the identification of new therapeutic targets for the prevention and treatment of atherosclerosis.CrossRefPubMedCentralPubMed
14.
16.
go back to reference Sims FH. The initiation of intimal thickening in human arteries. Pathology. 2000;32(3):171–5.PubMed Sims FH. The initiation of intimal thickening in human arteries. Pathology. 2000;32(3):171–5.PubMed
17.
go back to reference Jeziorska M, Woolley DE. Neovascularization in early atherosclerotic lesions of human carotid arteries: its potential contribution to plaque development. Hum Pathol. 1999;30(8):919–25.CrossRefPubMed Jeziorska M, Woolley DE. Neovascularization in early atherosclerotic lesions of human carotid arteries: its potential contribution to plaque development. Hum Pathol. 1999;30(8):919–25.CrossRefPubMed
18.
20.
22.
24.
go back to reference Nishi K, Oda T, Takabuchi S, et al. LPS induces hypoxia-inducible factor 1 activation in macrophage-differentiated cells in a reactive oxygen species-dependent manner. Antioxid Redox Signal. 2008;10(5):983–95. doi:10.1089/ars.2007.1825.CrossRefPubMed Nishi K, Oda T, Takabuchi S, et al. LPS induces hypoxia-inducible factor 1 activation in macrophage-differentiated cells in a reactive oxygen species-dependent manner. Antioxid Redox Signal. 2008;10(5):983–95. doi:10.​1089/​ars.​2007.​1825.CrossRefPubMed
25.•
go back to reference Marsch E, Theelen TL, Demandt JA, et al. Reversal of hypoxia in murine atherosclerosis prevents necrotic core expansion by enhancing efferocytosis. Arterioscler Thromb Vasc Biol. 2014;34(12):2545–53. doi:10.1161/ATVBAHA.114.304023. This article demonstrates that hypoxia may be indeed a contributing factor to the development atherosclerosis, whereas improved oxygenation reduces the development of atherosclerotic plaque lesions.CrossRefPubMed Marsch E, Theelen TL, Demandt JA, et al. Reversal of hypoxia in murine atherosclerosis prevents necrotic core expansion by enhancing efferocytosis. Arterioscler Thromb Vasc Biol. 2014;34(12):2545–53. doi:10.​1161/​ATVBAHA.​114.​304023. This article demonstrates that hypoxia may be indeed a contributing factor to the development atherosclerosis, whereas improved oxygenation reduces the development of atherosclerotic plaque lesions.CrossRefPubMed
27.
go back to reference Ramkhelawon B, Yang Y, van Gils JM, et al. Hypoxia induces netrin-1 and Unc5b in atherosclerotic plaques: mechanism for macrophage retention and survival. Arterioscler Thromb Vasc Biol. 2013;33(6):1180–8. doi:10.1161/ATVBAHA.112.301008. This article presents data that hypoxia may promote the inflammatory responses in atherosclerotic plaque lesion by promoting the expression of macrophage retention proteins, thus keeping macrophages in plaque tissues where they contribute to further plaque growth.CrossRefPubMedCentralPubMed Ramkhelawon B, Yang Y, van Gils JM, et al. Hypoxia induces netrin-1 and Unc5b in atherosclerotic plaques: mechanism for macrophage retention and survival. Arterioscler Thromb Vasc Biol. 2013;33(6):1180–8. doi:10.​1161/​ATVBAHA.​112.​301008. This article presents data that hypoxia may promote the inflammatory responses in atherosclerotic plaque lesion by promoting the expression of macrophage retention proteins, thus keeping macrophages in plaque tissues where they contribute to further plaque growth.CrossRefPubMedCentralPubMed
31.
go back to reference Fan J, Watanabe T. Inflammatory reactions in the pathogenesis of atherosclerosis. J Atheroscler Thromb. 2003;10(2):63–71.CrossRefPubMed Fan J, Watanabe T. Inflammatory reactions in the pathogenesis of atherosclerosis. J Atheroscler Thromb. 2003;10(2):63–71.CrossRefPubMed
32.
go back to reference Fukuchi M, Watanabe J, Kumagai K, et al. Normal and oxidized low density lipoproteins accumulate deep in physiologically thickened intima of human coronary arteries. Lab Invest. 2002;82(10):1437–47.CrossRefPubMed Fukuchi M, Watanabe J, Kumagai K, et al. Normal and oxidized low density lipoproteins accumulate deep in physiologically thickened intima of human coronary arteries. Lab Invest. 2002;82(10):1437–47.CrossRefPubMed
33.
go back to reference Nakashima Y, Fujii H, Sumiyoshi S, Wight TN, Sueishi K. Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration. Arterioscler Thromb Vasc Biol. 2007;27(5):1159–65. doi:10.1161/ATVBAHA.106.134080.CrossRefPubMed Nakashima Y, Fujii H, Sumiyoshi S, Wight TN, Sueishi K. Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration. Arterioscler Thromb Vasc Biol. 2007;27(5):1159–65. doi:10.​1161/​ATVBAHA.​106.​134080.CrossRefPubMed
36.
39.•
go back to reference Lee SJ, Thien Quach CH, Jung KH, et al. Oxidized low-density lipoprotein stimulates macrophage 18F-FDG uptake via hypoxia-inducible factor-1alpha activation through Nox2-dependent reactive oxygen species generation. J Nucl Med. 2014;55(10):1699–705. doi:10.2967/jnumed.114.139428. This paper links three aspects of atherosclerosis: oxLDL uptake, hypoxia, and glucose uptake for glycolysis.CrossRefPubMed Lee SJ, Thien Quach CH, Jung KH, et al. Oxidized low-density lipoprotein stimulates macrophage 18F-FDG uptake via hypoxia-inducible factor-1alpha activation through Nox2-dependent reactive oxygen species generation. J Nucl Med. 2014;55(10):1699–705. doi:10.​2967/​jnumed.​114.​139428. This paper links three aspects of atherosclerosis: oxLDL uptake, hypoxia, and glucose uptake for glycolysis.CrossRefPubMed
42.
go back to reference Shatrov VA, Sumbayev VV, Zhou J, Brune B. Oxidized low-density lipoprotein (oxLDL) triggers hypoxia-inducible factor-1alpha (HIF-1alpha) accumulation via redox-dependent mechanisms. Blood. 2003;101(12):4847–9. doi:10.1182/blood-2002-09-2711.CrossRefPubMed Shatrov VA, Sumbayev VV, Zhou J, Brune B. Oxidized low-density lipoprotein (oxLDL) triggers hypoxia-inducible factor-1alpha (HIF-1alpha) accumulation via redox-dependent mechanisms. Blood. 2003;101(12):4847–9. doi:10.​1182/​blood-2002-09-2711.CrossRefPubMed
43.
go back to reference Epstein AC, Gleadle JM, McNeill LA, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 2001;107(1):43–54.CrossRefPubMed Epstein AC, Gleadle JM, McNeill LA, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 2001;107(1):43–54.CrossRefPubMed
44.
go back to reference Giannarelli C, Alique M, Rodriguez DT, et al. Alternatively spliced tissue factor promotes plaque angiogenesis through the activation of hypoxia-inducible factor-1alpha and vascular endothelial growth factor signaling. Circulation. 2014;130(15):1274–86. doi:10.1161/CIRCULATIONAHA.114.006614.CrossRefPubMed Giannarelli C, Alique M, Rodriguez DT, et al. Alternatively spliced tissue factor promotes plaque angiogenesis through the activation of hypoxia-inducible factor-1alpha and vascular endothelial growth factor signaling. Circulation. 2014;130(15):1274–86. doi:10.​1161/​CIRCULATIONAHA.​114.​006614.CrossRefPubMed
47.
go back to reference Schmeisser A, Marquetant R, Illmer T, et al. The expression of macrophage migration inhibitory factor 1alpha (MIF 1alpha) in human atherosclerotic plaques is induced by different proatherogenic stimuli and associated with plaque instability. Atherosclerosis. 2005;178(1):83–94. doi:10.1016/j.atherosclerosis.2004.08.038.CrossRefPubMed Schmeisser A, Marquetant R, Illmer T, et al. The expression of macrophage migration inhibitory factor 1alpha (MIF 1alpha) in human atherosclerotic plaques is induced by different proatherogenic stimuli and associated with plaque instability. Atherosclerosis. 2005;178(1):83–94. doi:10.​1016/​j.​atherosclerosis.​2004.​08.​038.CrossRefPubMed
52.•
go back to reference Crucet M, Wust SJ, Spielmann P, Luscher TF, Wenger RH, Matter CM. Hypoxia enhances lipid uptake in macrophages: role of the scavenger receptors Lox1, SRA, and CD36. Atherosclerosis. 2013;229(1):110–7. doi:10.1016/j.atherosclerosis.2013.04.034. This publication illustrates an example how hypoxia may promote the uptake of oxLDL into macrophages. This represents one of the multiple mechanisms by which hypoxia activates processes that lead to the growth of atherosclerotic plaques.CrossRefPubMed Crucet M, Wust SJ, Spielmann P, Luscher TF, Wenger RH, Matter CM. Hypoxia enhances lipid uptake in macrophages: role of the scavenger receptors Lox1, SRA, and CD36. Atherosclerosis. 2013;229(1):110–7. doi:10.​1016/​j.​atherosclerosis.​2013.​04.​034. This publication illustrates an example how hypoxia may promote the uptake of oxLDL into macrophages. This represents one of the multiple mechanisms by which hypoxia activates processes that lead to the growth of atherosclerotic plaques.CrossRefPubMed
53.
64.
67.
go back to reference Nakano M, Fukumoto Y, Satoh K, et al. OX40 ligand plays an important role in the development of atherosclerosis through vasa vasorum neovascularization. Cardiovasc Res. 2010;88(3):539–46. doi:10.1093/cvr/cvq211.CrossRefPubMed Nakano M, Fukumoto Y, Satoh K, et al. OX40 ligand plays an important role in the development of atherosclerosis through vasa vasorum neovascularization. Cardiovasc Res. 2010;88(3):539–46. doi:10.​1093/​cvr/​cvq211.CrossRefPubMed
71.
go back to reference Christoph M, Ibrahim K, Hesse K, et al. Local inhibition of hypoxia-inducible factor reduces neointima formation after arterial injury in ApoE-/- mice. Atherosclerosis. 2014;233(2):641–7. doi:10.1016/j.atherosclerosis.2014.01.048. This article directly demonstrates that atherosclerotic plaque growth can be inhibited by suppressing the expression of hypoxia-inducible factor in injured arterial wall tissues.CrossRefPubMed Christoph M, Ibrahim K, Hesse K, et al. Local inhibition of hypoxia-inducible factor reduces neointima formation after arterial injury in ApoE-/- mice. Atherosclerosis. 2014;233(2):641–7. doi:10.​1016/​j.​atherosclerosis.​2014.​01.​048. This article directly demonstrates that atherosclerotic plaque growth can be inhibited by suppressing the expression of hypoxia-inducible factor in injured arterial wall tissues.CrossRefPubMed
75.
go back to reference Inoue S, Egashira K, Ni W, et al. Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice. Circulation. 2002;106(21):2700–6.CrossRefPubMed Inoue S, Egashira K, Ni W, et al. Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice. Circulation. 2002;106(21):2700–6.CrossRefPubMed
76.
go back to reference Bekkering S, Quintin J, Joosten LA, van der Meer JW, Netea MG, Riksen NP. Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes. Arterioscler Thromb Vasc Biol. 2014;34(8):1731–8. doi:10.1161/ATVBAHA.114.303887.CrossRefPubMed Bekkering S, Quintin J, Joosten LA, van der Meer JW, Netea MG, Riksen NP. Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes. Arterioscler Thromb Vasc Biol. 2014;34(8):1731–8. doi:10.​1161/​ATVBAHA.​114.​303887.CrossRefPubMed
77.
go back to reference Kiyan Y, Tkachuk S, Hilfiker-Kleiner D, Haller H, Fuhrman B, Dumler I. oxLDL induces inflammatory responses in vascular smooth muscle cells via urokinase receptor association with CD36 and TLR4. J Mol Cell Cardiol. 2014;66:72–82. 10.1016/j.yjmcc.2013.11.005.CrossRefPubMed Kiyan Y, Tkachuk S, Hilfiker-Kleiner D, Haller H, Fuhrman B, Dumler I. oxLDL induces inflammatory responses in vascular smooth muscle cells via urokinase receptor association with CD36 and TLR4. J Mol Cell Cardiol. 2014;66:72–82. 10.1016/j.yjmcc.2013.11.005.CrossRefPubMed
80.
go back to reference Roiniotis J, Dinh H, Masendycz P, et al. Hypoxia prolongs monocyte/macrophage survival and enhanced glycolysis is associated with their maturation under aerobic conditions. J Immunol. 2009;182(12):7974–81. doi:10.4049/jimmunol.0804216.CrossRefPubMed Roiniotis J, Dinh H, Masendycz P, et al. Hypoxia prolongs monocyte/macrophage survival and enhanced glycolysis is associated with their maturation under aerobic conditions. J Immunol. 2009;182(12):7974–81. doi:10.​4049/​jimmunol.​0804216.CrossRefPubMed
82.
go back to reference Wang Y, Zhou Y, He L, et al. Gene delivery of soluble vascular endothelial growth factor receptor-1 (sFlt-1) inhibits intra-plaque angiogenesis and suppresses development of atherosclerotic plaque. Clin Exp Med. 2011;11(2):113–21. doi:10.1007/s10238-010-0112-7.CrossRefPubMed Wang Y, Zhou Y, He L, et al. Gene delivery of soluble vascular endothelial growth factor receptor-1 (sFlt-1) inhibits intra-plaque angiogenesis and suppresses development of atherosclerotic plaque. Clin Exp Med. 2011;11(2):113–21. doi:10.​1007/​s10238-010-0112-7.CrossRefPubMed
83.
go back to reference Moulton KS, Heller E, Konerding MA, Flynn E, Palinski W, Folkman J. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation. 1999;99(13):1726–32.CrossRefPubMed Moulton KS, Heller E, Konerding MA, Flynn E, Palinski W, Folkman J. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation. 1999;99(13):1726–32.CrossRefPubMed
84.
go back to reference Qiao Y, Zhang PJ, Lu XT, et al. Panax notoginseng saponins inhibits atherosclerotic plaque angiogenesis by down-regulating vascular endothelial growth factor and nicotinamide adenine dinucleotide phosphate oxidase subunit 4 expression. Chin J Integr Med. 2014. doi:10.1007/s11655-014-1832-4. Qiao Y, Zhang PJ, Lu XT, et al. Panax notoginseng saponins inhibits atherosclerotic plaque angiogenesis by down-regulating vascular endothelial growth factor and nicotinamide adenine dinucleotide phosphate oxidase subunit 4 expression. Chin J Integr Med. 2014. doi:10.​1007/​s11655-014-1832-4.
Metadata
Title
Potential Contributions of Intimal and Plaque Hypoxia to Atherosclerosis
Author
Guo-Hua Fong
Publication date
01-06-2015
Publisher
Springer US
Published in
Current Atherosclerosis Reports / Issue 6/2015
Print ISSN: 1523-3804
Electronic ISSN: 1534-6242
DOI
https://doi.org/10.1007/s11883-015-0510-0

Other articles of this Issue 6/2015

Current Atherosclerosis Reports 6/2015 Go to the issue

Women and Ischemic Heart Disease (M Gulati, Section Editor)

ICD and CRT Use in Ischemic Heart Disease in Women

Vascular Biology (T Hla, Section Editor)

Fibroblast Growth Factor Signaling in the Vasculature

Women and Ischemic Heart Disease (M Gulati, Section Editor)

PAD in Women: the Ischemic Continuum

Women and Ischemic Heart Disease (M Gulati, Section Editor)

Sex Differences in the Pathophysiology, Treatment, and Outcomes in IHD

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.